Infinium Names Rose CEO

chicago
Rose formely headed up the firm's market making and algorithmic trading operations.

Infinium Capital Management has promoted Scott Rose to the role of CEO.

Rose previously served as head of trading, including its market making and algorithmic divisions, at the proprietary firm, which has offices in Chicago, New York, and London. Prior to Infinium, he held positions at Fox River Investment Services, Citadel Investment Group, Bank of America and Chicago Research and Trading Group.

With Rose's move, current founder and CEO Charles Whitman will take on the post of chairman.

"Since joining Infinium in 2010, Scott has brought unparalleled expertise and insights to our business enabling us to enhance our position as one of the foremost providers of liquidity across our markets," says Whitman. "I am confident that Scott's deep experience in trading and technology, as well as his demonstrated success as a business builder, will ensure that Infinium continues to grow and develop in the future."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Systematic tools gain favor in fixed income

Automation is enabling systematic strategies in fixed income that were previously reserved for equities trading. The tech gap between the two may be closing, but differences remain.

Why recent failures are a catalyst for DLT’s success

Deutsche Bank’s Mathew Kathayanat and Jie Yi Lee argue that DLT's high-profile failures don't mean the technology is dead. Now that the hype has died down, the path is cleared for more measured decisions about DLT’s applications.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here